Deficiency in Dipeptidyl Peptidase-4 Promotes Chemoresistance Through the CXCL12/CXCR4/mTOR/TGFβ Signaling Pathway in Breast Cancer Cells

Dipeptidyl peptidase (DPP)-4, a molecular target of DPP-4 inhibitors, which are type 2 diabetes drugs, is expressed in a variety of cell types, tissues and organs. DPP-4 has been shown to be involved in cancer biology, and we have recently shown that a DPP-4 inhibitor promoted the epithelial mesench...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Shaolan, Fan, Yang, Kumagai, Asako, Kawakita, Emi, Kitada, Munehiro, Kanasaki, Keizo, Koya, Daisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037814/
https://www.ncbi.nlm.nih.gov/pubmed/31991851
http://dx.doi.org/10.3390/ijms21030805

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7037814/
https://www.ncbi.nlm.nih.gov/pubmed/31991851
http://dx.doi.org/10.3390/ijms21030805

Ejemplares similares